CRISPR/Cas9 technology replaced exon 9 with exons containing a serine to alanine substitution at amino acid 667 (S667A), a serine to glutamate substitution at amino acid 737 (S737E), and a serine to glutamate substitution at amino acid 760 (S760E). This knock-in mimics MAP4 hyperphosphorylation at S737 and S760 and unphosphorylated S667 which is seen in tetralogy of Fallot patients. (J:278780)
Legend:
cx: complex: > 1 genome feature ot: other: hemizygous, indeterminate,... (F): Female
(M): Male
N: normal phenotype
(#): related diseases count